Next-generation ovarian cancer therapy: Engineered Vδ2 T cells show promise in preclinical trials Post author: Post published:November 13, 2023 Post category:uncategorized A prospective path for allogeneic cellular immunotherapies. You Might Also Like Zero coronary artery calcium score predicts low heart risk at any age March 30, 2025 Simple hospital menu changes could deliver major health and climate benefits September 22, 2025 Can creatine help with depression? New review says results are inconclusive November 6, 2025